Queen’s University Belfast-led research reports on a multicenter trial finding no significant reduction in pulmonary exacerbations with hypertonic saline or carbocisteine over 52 weeks among adults with non–cystic fibrosis bronchiectasis.
This article was originally published on MedicalXpress.com